Biopharmaceutical Testing Services | Charles River

cell line characterization 

cell line characterization services 

The characterization of cell banks is essential to ensure the quality of cell-derived biopharmaceutical products. Cell banks must be extensively characterized to demonstrate that the cell line is not contaminated with other cell lines, adventitious or endogenous agents, or molecular contaminants. However, the test design for the characterization of mammalian, microbial and other cell lines is species-specific and can vary depending on the history of the cell line and the type of media components that may be present.

Charles River Biopharmaceutical Services (BPS) can advise you in the design and execution of a complete testing program for your cell line that is customized to meet your exact specifications and is compliant with international regulatory guidelines. All tests required to demonstrate the suitability of the cell line must be compliant with current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (GLP) using validated test procedures and be in agreement with international guidelines

Charles River offers the specialized expertise and rigorous biochemical, molecular and virological tests that ensure the identity, purity, stability and safety of your cell banks. Our cell line characterization programs are designed to include testing panels that detect the presence of contaminants and verify cell line identity for master cell banks (MCB), working cell banks (WCB), research cell banks (RCB) and end-of-production cells (EOPC) or cells at the limit of in vitro age (CAL) as designated by the International Conference on Harmonisation (ICH). We offer these assays for the following expression systems:


For more information, please contact us at askcharlesriver@crl.com or 1.877.CRIVER.1.

 
Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Aug 06 - Harmonized Clinical Sample Kits fo...
Jul 29 - CR and WuXi Terminate Agreement
Sep 08-Sep 11 - Kyoto, Japan - 2010 World Molecular Imaging Congress
Sep 13-Sep 15 - San Diego, CA - 16th Annual Symposium on Biotechnology-Derived Therapeu...
view all
Director, Clinical Specialist Sales 
Manager Corporate Consolidation Wilmingto...
IT Specialist II - Web Development  
Senior Tax Analyst Wilmington, MA

Charles River Laboratories, Inc.